Round Type
Venture
BaltimoreBiotechnologyHealth CareSportsDescription
KaloCyte, Inc., a developer of bio-inspired red blood cell substitute ErythroMerTM, today announced it has closed an investment from New York Blood Center, Inc. (NYBC).
Quick answer
KaloCyte raised an undisclosed amount in a funding round, dated July 20, 2022. KaloCyte is based in Baltimore, Maryland, United States.
- How much did KaloCyte raise?
- KaloCyte raised an undisclosed amount in a funding round on July 20, 2022.
- What does KaloCyte do?
- KaloCyte is redefining future emergency treatment for victims of traumatic blood loss with its first-in-class product ErythroMer, a dried red blood cell substitute that is easily transported and rapidly administered for..
- Where is KaloCyte based and how big is it?
- KaloCyte is based in Baltimore, Maryland, United States.
Source: Fundz verified event record.
Who else raised in Sports and Biotechnology around the same time
Companies in the same sectors as KaloCyte that raised within 45 days of this round, from Fundz verified event records.
- TendoNova raised $215K (Seed) on July 29, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- Monteris Medical raised $14M on September 2, 2022.
- Ostial Corporation raised $7.7M on September 1, 2022.
- FathomX raised an undisclosed amount (Pre-Series A) on September 1, 2022.
- JenaValve raised $100M (Funding Round) on August 31, 2022.
Who to call at KaloCyte, and when
A new round usually means KaloCyte is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day KaloCyte raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KaloCyte, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KaloCyte. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KaloCyte raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
KaloCyte raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.